Results 101 to 110 of about 25,017 (220)
HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.
PLoS Pathogens, 2007 The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120 is a vaccine immunogen that can signal via several cell surface receptors.
Meimei Shan +10 more
doaj +1 more source
Neutralization of feline immunodeficiency virus by antibodies targeting the V5 loop of Env [PDF]
, 2010 Neutralising antibodies (NAbs) play a vital role in vaccine-induced protection against infection with feline immunodeficiency virus (FIV). However, little is known about the appropriate presentation of neutralisation epitopes in order to induce NAbs ...
Hosie, Margaret J. +6 more
core +1 more source
Nanostructured Electrochemical Sensors for Rapid HIV Detection
Journal of Sensors, Volume 2026, Issue 1, 2026.Many significant and transmissible diseases, including human immunodeficiency virus (HIV)/acquired immune deficiency syndrome (AIDS), COVID‐19, hepatitis, and influenza, are caused by viruses. The rapid replication ability of these viruses is the primary reason for their widespread transmission, resulting in consequences such as loss of life at both ...
Dharmesh Kumar +3 more
wiley +1 more source
Preliminary evaluation of KYNA ameliorates neuronal pyroptosis induced by HIV-1 gp120
International Journal of Infectious DiseasesBackgrounds: HIV-associated neurocognitive disorders (HAND) are the common complications in the central nervous system (CNS), mainly causing HIV dementia and leading to serious social economic load.
Dr Xuefeng Gao +5 more
doaj +1 more source
eLife, 2015 The HIV-1 envelope protein gp120 is both the target of neutralizing antibodies and a major focus of vaccine efforts; however how it is delivered to B cells to elicit an antibody response is unknown.
Chung Park +3 more
doaj +1 more source
Health Science Reports, Volume 8, Issue 11, November 2025.ABSTRACT Background and Aims SARS‐CoV‐2 continues to pose global challenges, and current vaccines face limitations (variant escape, waning immunity). This review evaluates immunostimulatory adjuvants and nano‐adjuvants to enhance immune responses and optimize SARS‐CoV‐2 vaccine performance.
Peyman Kheirandish Zarandi +5 more
wiley +1 more source
Search for antiviral functions of potentially protective antibodies against V2 region of HIV-1
Human Vaccines & Immunotherapeutics, 2020 In the only successful RV144 vaccine trial to date, high levels of antibodies (Abs) against the V2 region of the virus envelope protein gp120 correlated with reduced HIV-1 infection.
Miroslaw K. Gorny
doaj +1 more source
Discrete partitioning of HIV-1 Env forms revealed by viral capture [PDF]
, 2015 BACKGROUND: The structure of HIV-1 envelope glycoprotein (Env) is flexible and heterogeneous on whole virions. Although functional Env complexes are thought to require trimerization of cleaved gp41/gp120 heterodimers, variable processing can result in ...
Aldon, Y +5 more
core +3 more sources
Journal of Extracellular Biology, Volume 4, Issue 11, November 2025.The characterization of EVs and viruses co‐purified by differential centrifugation highlighted their diversity. The 3K pellet contained viruses with high infectivity, along with DAP‐3 and mitochondrial DNA enriched EVs. A lower infectivity was associated with the 17K pellet. The 17K EVs displayed ICAM‐1 and contained HSP70 and mitochondrial DNA.
Julien Boucher +2 more
wiley +1 more source
International Journal of Nanomedicine, 2014 Yuri D Ivanov,1 Natalia S Bukharina,1 Tatyana O Pleshakova,1 Pavel A Frantsuzov,1 Elena Yu Andreeva,1 Anna L Kaysheva,1,2 Victor G Zgoda,1 Alexander A Izotov,1 Tatyana I Pavlova,1 Vadim S Ziborov,1 Sergey P Radko,1 Sergei A Moshkovskii,1 Alexander I ...
Ivanov YD +12 more
doaj